Sinofert Holdings Past Earnings Performance
Past criteria checks 2/6
Sinofert Holdings has been growing earnings at an average annual rate of 7.9%, while the Chemicals industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 0.7% per year. Sinofert Holdings's return on equity is 6.5%, and it has net margins of 3%.
Key information
7.9%
Earnings growth rate
7.9%
EPS growth rate
| Chemicals Industry Growth | 10.2% |
| Revenue growth rate | -0.7% |
| Return on equity | 6.5% |
| Net Margin | 3.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Sinofert Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 22,281 | 673 | 1,266 | 0 |
| 31 Mar 24 | 22,005 | 649 | 1,245 | 0 |
| 31 Dec 23 | 21,728 | 626 | 1,224 | 0 |
| 30 Sep 23 | 21,276 | 874 | 1,258 | 0 |
| 30 Jun 23 | 20,824 | 1,123 | 1,292 | 0 |
| 31 Mar 23 | 21,913 | 1,120 | 1,281 | 0 |
| 31 Dec 22 | 23,003 | 1,117 | 1,269 | 0 |
| 30 Sep 22 | 23,676 | 1,159 | 1,209 | 0 |
| 30 Jun 22 | 24,350 | 1,202 | 1,149 | 0 |
| 31 Mar 22 | 23,496 | 1,034 | 1,220 | 0 |
| 31 Dec 21 | 22,641 | 867 | 1,292 | 0 |
| 30 Sep 21 | 22,535 | 863 | 1,387 | 0 |
| 30 Jun 21 | 22,429 | 860 | 1,482 | 0 |
| 31 Mar 21 | 21,905 | 752 | 1,448 | 0 |
| 31 Dec 20 | 21,381 | 644 | 1,414 | 0 |
| 30 Sep 20 | 21,361 | 630 | 1,403 | 0 |
| 30 Jun 20 | 21,341 | 616 | 1,393 | 0 |
| 31 Mar 20 | 22,146 | 616 | 1,429 | 0 |
| 31 Dec 19 | 22,951 | 616 | 1,464 | 0 |
| 30 Sep 19 | 23,534 | 605 | 1,485 | 0 |
| 30 Jun 19 | 24,118 | 593 | 1,505 | 0 |
| 31 Mar 19 | 23,557 | 527 | 1,523 | 0 |
| 31 Dec 18 | 22,996 | 460 | 1,541 | 0 |
| 30 Sep 18 | 21,604 | -723 | 1,554 | 0 |
| 30 Jun 18 | 20,212 | -1,906 | 1,566 | 0 |
| 31 Mar 18 | 18,928 | -2,057 | 1,527 | 0 |
| 31 Dec 17 | 17,644 | -2,208 | 1,489 | 0 |
| 30 Sep 17 | 17,082 | -3,199 | 1,499 | 0 |
| 30 Jun 17 | 16,520 | -4,191 | 1,509 | 0 |
| 31 Mar 17 | 15,739 | -4,413 | 1,513 | 0 |
| 31 Dec 16 | 14,959 | -4,636 | 1,518 | 0 |
| 30 Sep 16 | 16,644 | -2,595 | 1,480 | 0 |
| 30 Jun 16 | 18,329 | -553 | 1,443 | 0 |
| 31 Mar 16 | 22,225 | -166 | 1,411 | 0 |
| 31 Dec 15 | 26,121 | 221 | 1,378 | 0 |
| 30 Sep 15 | 27,627 | 327 | 1,411 | 0 |
| 30 Jun 15 | 29,132 | 434 | 1,444 | 0 |
| 31 Mar 15 | 28,721 | 332 | 1,443 | 0 |
| 31 Dec 14 | 28,311 | 229 | 1,441 | 0 |
| 30 Sep 14 | 29,167 | -231 | 1,441 | 0 |
| 30 Jun 14 | 30,022 | -691 | 1,442 | 0 |
| 31 Mar 14 | 32,372 | -584 | 1,465 | 0 |
| 31 Dec 13 | 34,722 | -476 | 1,488 | 0 |
Quality Earnings: 297 has high quality earnings.
Growing Profit Margin: 297's current net profit margins (3%) are lower than last year (5.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 297 has become profitable over the past 5 years, growing earnings by 7.9% per year.
Accelerating Growth: 297's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 297 had negative earnings growth (-40.1%) over the past year, making it difficult to compare to the Chemicals industry average (-29.6%).
Return on Equity
High ROE: 297's Return on Equity (6.5%) is considered low.